Tissue Diagnostics Market by Product (Consumables, Instruments), Technology (Immunohistochemistry, in Situ Hybridization, Digital Pathology & Workflow), Disease (Breast Cancer, Gastric Cancer, Lymphoma), End User (Hospital, CRO) - Global Forecast to 2022

 Published On: Nov, 2017 |    No of Pages: 162 |  Published By: MarketsandMarkets | Format: PDF
Request Free Sample
Global tissue diagnostics market projected to grow at a CAGR of 6.9% during the forecast period

The tissue diagnostics market is expected to reach USD 5.14 billion by 2022 from USD 3.68 billion in 2017, at a CAGR of 6.9%. Factors driving the growth of this market include the rising incidence of cancer, growing healthcare expenditure, improving infrastructure for cancer diagnosis, and technological advancements in tissue diagnostics. On the other hand, complex regulatory frameworks that delay the approval of new diagnostic products and lack of infrastructure are expected to challenge market growth to a certain extent.

The breast cancer segment is anticipated to grow at the fastest growth rate during the forecast period

The tissue diagnostics market by disease, is categorized into breast cancer, gastric cancer, lymphoma, prostate cancer, NSCLC, and other diseases. The breast cancer segment is expected to grow at the highest CAGR during the forecast period. The growing use of tissue diagnostics for the diagnosis of breast cancer, increasing awareness regarding breast cancer, and the development of novel products are the key factor driving the growth of this market.

The research laboratories segment is estimated to grow at a rapid rate during the analysis period

By end user, the tissue diagnostics market is segmented into hospitals, pharmaceutical companies, research laboratories, contract research organizations, and other end users. The research laboratories segment is expected to remain the fastest-growing segment of the global tissue diagnostics market during the forecast period. Factors such as the rising number of cancer drug trials and growing research activities to design novel biomarkers for tissue diagnosis are driving the growth of this segment.

Asia is estimated to grow at the highest CAGR during the study period

Geographically, the tissue diagnostics market is dominated by North America, followed by Europe in 2017, however, Asia is estimated to grow at the fastest rate during the forecast period. Growth in this region can be attributed to developing healthcare infrastructure, rising burden of cancer, and increasing initiatives to promote the use of novel technologies for tissue diagnostics in Asian countries.

The primary interviews conducted for this report can be categorized as follows:

• By Company Type - Tier 1 – 70% and Tier 2 – 30%
• By Designation – C level – 62%, Director level – 21%, Others – 17%
• By Region – North America – 50%, Europe – 20%, Asia– 30%

The key players in the tissue diagnostics market include Roche (Switzerland), Danaher (US), Thermo Fisher Scientific (US), Abbott (US), Agilent Technologies (US), Merck (Germany), Sakura Finetek Japan (Japan), Abcam (UK), BD (US), QIAGEN (Netherlands), Sienna Cancer Diagnostics (Australia), Royal Philips (Netherlands), A. Menarini Diagnostics (Italy), Cell Signaling Technology (US), Enzo Life Sciences (US), Master Diagnσstica (Spain), TissueGnostics (Austria), Bio SB (US), MedImmune (US), Cernostics (US), Zenalux Biomedical (US), 3DHISTECH (Hungary), Lunaphore Technologies (Switzerland), BioGenex (US), and Biocare Medical (US).

Research Coverage:

The report analyses the tissue diagnostics market by product, technology, disease, end user, and region. Apart from a comprehensive geographic product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles include the product portfolios, developments, and strategies adopted by prominent market players to maintain and increase their shares in the market. Market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output to remain successful in the market.

Key benefits of buying the Report:

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on the product portfolios of the top players in the tissue diagnostics market
• Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the tissue diagnostics market
• Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the tissue diagnostics market
• Market Development: Comprehensive information about emerging markets. This report analyzes the market for various tissue diagnostics products and services across geographies
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the tissue diagnostics market
TABLE OF CONTENTS

1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION 15
1.3 MARKET SCOPE 16
1.3.1 MARKETS COVERED 16
1.3.2 YEARS CONSIDERED FOR THE STUDY 17
1.4 CURRENCY 17
1.5 LIMITATIONS 17
1.6 STAKEHOLDERS 17

2 RESEARCH METHODOLOGY 18
2.1 RESEARCH DATA 18
2.1.1 SECONDARY DATA 19
2.1.1.1 Key data from secondary sources 19
2.1.2 PRIMARY DATA 20
2.1.2.1 Key data from primary sources 20
2.1.2.2 Breakdown of primaries 21
2.2 MARKET SIZE ESTIMATION 21
2.2.1 BOTTOM-UP APPROACH 22
2.2.2 TOP-DOWN APPROACH 23
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 24
2.4 RESEARCH ASSUMPTIONS 25

3 EXECUTIVE SUMMARY 26

4 PREMIUM INSIGHTS 30
4.1 TISSUE DIAGNOSTICS: MARKET OVERVIEW 30
4.2 GEOGRAPHIC ANALYSIS: TISSUE DIAGNOSTICS MARKET IN ASIA, BY COUNTRY AND TECHNOLOGY 31
4.3 GLOBAL TISSUE DIAGNOSTICS MARKET, BY END USER 32
4.4 GEOGRAPHICAL SNAPSHOT OF THE GLOBAL TISSUE DIAGNOSTICS MARKET 33

5 MARKET OVERVIEW 34
5.1 INTRODUCTION 34
5.2 MARKET DYNAMICS 34
5.2.1 DRIVERS 35
5.2.1.1 Rising incidence of cancer 35
5.2.1.2 Growing healthcare expenditure 35
5.2.1.3 Improving infrastructure for cancer diagnosis 36
5.2.1.4 Technological advancements in tissue diagnostics 37
5.2.2 RESTRAINTS 37
5.2.2.1 High degree of consolidation 37
5.2.3 OPPORTUNITIES 38
5.2.3.1 Emerging markets 38
5.2.3.2 Growing demand for personalized medicine 38
5.2.3.3 Rising number of clinical trials for cancer drugs 39
5.2.4 CHALLENGES 39
5.2.4.1 Stringent regulatory requirements 39
5.2.4.2 Lack of infrastructure and low awareness in middle- and low- income countries 39
5.2.5 TRENDS 40
5.2.5.1 Increasing number of reagent rental agreements 40

6 TISSUE DIAGNOSTICS MARKET, BY PRODUCT 41
6.1 INTRODUCTION 42
6.2 CONSUMABLES 43
6.2.1 ANTIBODIES 44
6.2.2 KITS 44
6.2.3 REAGENTS 45
6.2.4 PROBES 46
6.3 INSTRUMENTS 46
6.3.1 SLIDE-STAINING SYSTEMS 47
6.3.2 SCANNERS 48
6.3.3 TISSUE-PROCESSING SYSTEMS 49
6.3.4 OTHER INSTRUMENTS 49

7 TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY 51
7.1 INTRODUCTION 52
7.2 IMMUNOHISTOCHEMISTRY (IHC) 53
7.3 IN SITU HYBRIDIZATION (ISH) 54
7.4 DIGITAL PATHOLOGY AND WORKFLOW MANAGEMENT 55
7.5 SPECIAL STAINING 56

8 TISSUE DIAGNOSTICS MARKET, BY DISEASE 58
8.1 INTRODUCTION 59
8.2 BREAST CANCER 60
8.3 GASTRIC CANCER 61
8.4 LYMPHOMA 62
8.5 PROSTATE CANCER 63
8.6 NON-SMALL CELL LUNG CANCER (NSCLC) 64
8.7 OTHER DISEASES 65

9 TISSUE DIAGNOSTICS MARKET, BY END USER 66
9.1 INTRODUCTION 67
9.2 HOSPITALS 68
9.3 RESEARCH LABORATORIES 69
9.4 PHARMACEUTICAL COMPANIES 70
9.5 CONTRACT RESEARCH ORGANIZATIONS 71
9.6 OTHER END USERS 72

10 TISSUE DIAGNOSTICS MARKET, BY REGION 73
10.1 INTRODUCTION 74
10.2 NORTH AMERICA 75
10.2.1 US 81
10.2.2 CANADA 83
10.3 EUROPE 85
10.3.1 GERMANY 91
10.3.2 UK 93
10.3.3 FRANCE 95
10.3.4 ITALY 97
10.3.5 SPAIN 99
10.3.6 REST OF EUROPE (ROE) 101
10.4 ASIA 103
10.4.1 CHINA 108
10.4.2 JAPAN 110
10.4.3 INDIA 112
10.4.4 REST OF ASIA (ROA) 113
10.5 REST OF THE WORLD (ROW) 115

11 COMPETITIVE LANDSCAPE 121
11.1 INTRODUCTION 121
11.2 MARKET SHARE ANALYSIS 121

12 COMPANY PROFILES 123 (Business Overview, Strength of product Portfolio, Business Strategy Excellence, Recent Developments,)*
12.1 ROCHE 123
12.2 DANAHER 125
12.3 THERMO FISHER SCIENTIFIC 128
12.4 ABBOTT 131
12.5 AGILENT TECHNOLOGIES 133
12.6 MERCK 136
12.7 SAKURA FINETEK JAPAN 138
12.8 ABCAM 140
12.9 BD 142
12.10 QIAGEN 144
12.11 BIO SB 146
12.12 BIOGENEX 148
12.13 CELL SIGNALING TECHNOLOGY 150

*Details on Business Overview, Strength of product Portfolio, Business Strategy Excellence, Recent Developments, might not be captured in case of unlisted companies.

13 APPENDIX 152
13.1 INDUSTRY INSIGHTS 152
13.2 DISCUSSION GUIDE 153
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 156
13.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 158
13.5 AVAILABLE CUSTOMIZATIONS 159
13.6 RELATED REPORTS 159
13.7 AUTHOR DETAILS 160

LIST OF TABLES

TABLE 1 TISSUE DIAGNOSTICS: MARKET SNAPSHOT 26
TABLE 2 TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 42
TABLE 3 TISSUE DIAGNOSTICS MARKET FOR CONSUMABLES, BY TYPE, 2015–2022 (USD MILLION) 43
TABLE 4 TISSUE DIAGNOSTICS MARKET FOR CONSUMABLES, BY REGION, 2015–2022 (USD MILLION) 43
TABLE 5 TISSUE DIAGNOSTICS MARKET FOR ANTIBODIES, BY REGION, 2015–2022 (USD MILLION) 44
TABLE 6 TISSUE DIAGNOSTICS MARKET FOR KITS, BY REGION, 2015–2022 (USD MILLION) 45
TABLE 7 TISSUE DIAGNOSTICS MARKET FOR REAGENTS, BY REGION, 2015–2022 (USD MILLION) 45
TABLE 8 TISSUE DIAGNOSTICS MARKET FOR PROBES, BY REGION, 2015–2022 (USD MILLION) 46
TABLE 9 TISSUE DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2015–2022 (USD MILLION) 47
TABLE 10 TISSUE DIAGNOSTICS MARKET FOR INSTRUMENTS, BY REGION, 2015–2022 (USD MILLION) 47
TABLE 11 TISSUE DIAGNOSTICS MARKET FOR SLIDE-STAINING SYSTEMS, BY REGION, 2015–2022 (USD MILLION) 48
TABLE 12 TISSUE DIAGNOSTICS MARKET FOR SCANNERS, BY REGION, 2015–2022 (USD MILLION) 48
TABLE 13 TISSUE DIAGNOSTICS MARKET FOR TISSUE-PROCESSING SYSTEMS, BY REGION, 2015–2022 (USD MILLION) 49
TABLE 14 TISSUE DIAGNOSTICS MARKET FOR OTHER INSTRUMENTS, BY REGION, 2015–2022 (USD MILLION) 50
TABLE 15 TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION) 52
TABLE 16 TISSUE DIAGNOSTICS MARKET FOR IMMUNOHISTOCHEMISTRY, BY REGION, 2015-2022 (USD MILLION) 54
TABLE 17 TISSUE DIAGNOSTICS MARKET FOR IN SITU HYBRIDIZATION, BY REGION, 2015-2022 (USD MILLION) 55
TABLE 18 TISSUE DIAGNOSTICS MARKET FOR DIGITAL PATHOLOGY AND WORKFLOW MANAGEMENT, BY REGION, 2015-2022 (USD MILLION) 56
TABLE 19 TISSUE DIAGNOSTICS MARKET FOR SPECIAL STAINING, BY REGION, 2015-2022 (USD MILLION) 57
TABLE 20 TISSUE DIAGNOSTICS MARKET, BY DISEASE, 2015–2022 (USD MILLION) 60
TABLE 21 TISSUE DIAGNOSTICS MARKET FOR BREAST CANCER, BY REGION, 2015–2022 (USD MILLION) 61
TABLE 22 TISSUE DIAGNOSTICS MARKET FOR GASTRIC CANCER, BY REGION, 2015–2022 (USD MILLION) 62
TABLE 23 TISSUE DIAGNOSTICS MARKET FOR LYMPHOMA, BY REGION, 2015–2022 (USD MILLION) 62
TABLE 24 TISSUE DIAGNOSTICS MARKET FOR PROSTATE CANCER, BY REGION, 2015–2022 (USD MILLION) 63
TABLE 25 TISSUE DIAGNOSTICS MARKET FOR NON-SMALL CELL LUNG CANCER, BY REGION, 2015–2022 (USD MILLION) 64
TABLE 26 TISSUE DIAGNOSTICS MARKET FOR OTHER DISEASES, BY REGION, 2015–2022 (USD MILLION) 65
TABLE 27 TISSUE DIAGNOSTICS MARKET, BY END USER, 2015–2022 (USD MILLION) 67
TABLE 28 TISSUE DIAGNOSTICS MARKET FOR HOSPITALS, BY REGION, 2015–2022 (USD MILLION) 68
TABLE 29 TISSUE DIAGNOSTICS MARKET FOR RESEARCH LABORATORIES, BY REGION, 2015–2022 (USD MILLION) 69
TABLE 30 TISSUE DIAGNOSTICS MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2015–2022 (USD MILLION) 70
TABLE 31 TISSUE DIAGNOSTICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2015–2022 (USD MILLION) 71
TABLE 32 TISSUE DIAGNOSTICS MARKET FOR OTHER END USERS, BY REGION, 2015–2022 (USD MILLION) 72
TABLE 33 TISSUE DIAGNOSTICS MARKET, BY REGION, 2015–2022 (USD MILLION) 74
TABLE 34 NORTH AMERICA: TISSUE DIAGNOSTICS MARKET, BY COUNTRY, 2015–2022 (USD MILLION) 77
TABLE 35 NORTH AMERICA: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 78
TABLE 36 NORTH AMERICA: TISSUE DIAGNOSTICS MARKET FOR CONSUMABLES, BY TYPE, 2015–2022 (USD MILLION) 78
TABLE 37 NORTH AMERICA: TISSUE DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2015–2022 (USD MILLION) 79
TABLE 38 NORTH AMERICA: TISSUE DIAGNOSTICS MARKET, BY DISEASE, 2015–2022 (USD MILLION) 79
TABLE 39 NORTH AMERICA: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION) 80
TABLE 40 NORTH AMERICA: TISSUE DIAGNOSTICS MARKET, BY END USER, 2015–2022 (USD MILLION) 80
TABLE 41 US: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 82
TABLE 42 US: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION) 82
TABLE 43 US: TISSUE DIAGNOSTICS MARKET, BY END USER, 2015–2022 (USD MILLION) 82
TABLE 44 CANADA: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 84
TABLE 45 CANADA: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION) 84
TABLE 46 CANADA: TISSUE DIAGNOSTICS MARKET, BY END USER, 2015–2022 (USD MILLION) 84
TABLE 47 EUROPE: TISSUE DIAGNOSTICS MARKET, BY COUNTRY, 2015–2022 (USD MILLION) 87
TABLE 48 EUROPE: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 87
TABLE 49 EUROPE: TISSUE DIAGNOSTICS MARKET FOR CONSUMABLES, BY TYPE, 2015–2022 (USD MILLION) 88
TABLE 50 EUROPE: TISSUE DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2015–2022 (USD MILLION) 88
TABLE 51 EUROPE: TISSUE DIAGNOSTICS MARKET, BY DISEASE, 2015–2022 (USD MILLION) 89
TABLE 52 EUROPE: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION) 90
TABLE 53 EUROPE: TISSUE DIAGNOSTICS MARKET, BY END USER, 2015–2022 (USD MILLION) 90
TABLE 54 GERMANY: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 91
TABLE 55 GERMANY: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION) 92
TABLE 56 GERMANY: TISSUE DIAGNOSTICS MARKET, BY END USER, 2015–2022 (USD MILLION) 92
TABLE 57 UK: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 93
TABLE 58 UK: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION) 94
TABLE 59 UK: TISSUE DIAGNOSTICS MARKET, BY END USER, 2015–2022 (USD MILLION) 94
TABLE 60 FRANCE: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 95
TABLE 61 FRANCE: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION) 96
TABLE 62 FRANCE: TISSUE DIAGNOSTICS MARKET, BY END USER, 2015–2022 (USD MILLION) 96
TABLE 63 ITALY: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 97
TABLE 64 ITALY: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION) 98
TABLE 65 ITALY: TISSUE DIAGNOSTICS MARKET, BY END USER, 2015–2022 (USD MILLION) 98
TABLE 66 SPAIN: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 99
TABLE 67 SPAIN: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION) 100
TABLE 68 SPAIN: TISSUE DIAGNOSTICS MARKET, BY END USER, 2015–2022 (USD MILLION) 100
TABLE 69 ROE: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 101
TABLE 70 ROE: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION) 102
TABLE 71 ROE: TISSUE DIAGNOSTICS MARKET, BY END USER, 2015–2022 (USD MILLION) 102
TABLE 72 ASIA: TISSUE DIAGNOSTICS MARKET, BY COUNTRY, 2015–2022 (USD MILLION) 105
TABLE 73 ASIA: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 105
TABLE 74 ASIA: TISSUE DIAGNOSTICS MARKET FOR CONSUMABLES, BY TYPE, 2015–2022 (USD MILLION) 105
TABLE 75 ASIA: TISSUE DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2015–2022 (USD MILLION) 106
TABLE 76 ASIA: TISSUE DIAGNOSTICS MARKET, BY DISEASE, 2015–2022 (USD MILLION) 106
TABLE 77 ASIA: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION) 107
TABLE 78 ASIA: TISSUE DIAGNOSTICS MARKET, BY END USER, 2015–2022 (USD MILLION) 108
TABLE 79 CHINA: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 109
TABLE 80 CHINA: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION) 109
TABLE 81 CHINA: TISSUE DIAGNOSTICS MARKET, BY END USER, 2015–2022 (USD MILLION) 109
TABLE 82 JAPAN: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 110
TABLE 83 JAPAN: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION) 111
TABLE 84 JAPAN: TISSUE DIAGNOSTICS MARKET, BY END USER, 2015–2022 (USD MILLION) 111
TABLE 85 INDIA: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 112
TABLE 86 INDIA: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION) 112
TABLE 87 INDIA: TISSUE DIAGNOSTICS MARKET, BY END USER, 2015–2022 (USD MILLION) 113
TABLE 88 ROA: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 114
TABLE 89 ROA: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION) 114
TABLE 90 ROA: TISSUE DIAGNOSTICS MARKET, BY END USER, 2015–2022 (USD MILLION) 115
TABLE 91 ROW: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 117
TABLE 92 ROW: TISSUE DIAGNOSTICS MARKET FOR CONSUMABLES, BY TYPE, 2015–2022 (USD MILLION) 117
TABLE 93 ROW: TISSUE DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2015–2022 (USD MILLION) 118
TABLE 94 ROW: TISSUE DIAGNOSTICS MARKET, BY DISEASE, 2015–2022 (USD MILLION) 118
TABLE 95 ROW: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION) 119
TABLE 96 ROW: TISSUE DIAGNOSTICS MARKET, BY END USER, 2015–2022 (USD MILLION) 120

LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 18
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 21
FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 22
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 23
FIGURE 5 DATA TRIANGULATION METHODOLOGY 24
FIGURE 6 TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2017–2022 (USD BILLION) 27
FIGURE 7 TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017–2022 (USD BILLION) 27
FIGURE 8 TISSUE DIAGNOSTICS MARKET, BY DISEASE, 2017–2022 (USD BILLION) 28
FIGURE 9 TISSUE DIAGNOSTICS MARKET, BY END USER, 2017–2022 (USD BILLION) 28
FIGURE 10 TISSUE DIAGNOSTICS MARKET, BY REGION, 2017–2022 (USD BILLION) 29
FIGURE 11 RISING INCIDENCE OF CANCER TO DRIVE THE GROWTH OF THE TISSUE DIAGNOSTICS MARKET DURING THE FORECAST PERIOD 30
FIGURE 12 IMMUNOHISTOCHEMISTRY TO DOMINATE THE TISSUE DIAGNOSTICS MARKET IN ASIA IN 2017 31
FIGURE 13 RESEARCH LABORATORIES WILL REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 32
FIGURE 14 ASIA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 33
FIGURE 15 TISSUE DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, CHALLENGES, AND TRENDS 34
FIGURE 16 GLOBAL HEALTHCARE SPENDING, 2004–2014 36
FIGURE 17 GROWTH IN PER CAPITA HEALTHCARE EXPENDITURE IN BRICS COUNTRIES, 2004–2014 38
FIGURE 18 CONSUMABLES SEGMENT TO DOMINATE THE GLOBAL TISSUE DIAGNOSTICS PRODUCTS MARKET IN 2017 42
FIGURE 19 IMMUNOHISTOCHEMISTRY TO DOMINATE THE TISSUE DIAGNOSTICS TECHNOLOGY MARKET DURING THE FORECAST PERIOD 52
FIGURE 20 TISSUE DIAGNOSTICS MARKET, BY DISEASE, 2017 VS. 2022 (USD MILLION) 59
FIGURE 21 GLOBAL TISSUE DIAGNOSTICS MARKET, BY END USER, 2017 VS. 2022 (USD MILLION) 67
FIGURE 22 TISSUE DIAGNOSTICS MARKET IN ASIA TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 74
FIGURE 23 NORTH AMERICA: TISSUE DIAGNOSTICS MARKET SNAPSHOT 76
FIGURE 24 CONSUMABLES TO COMMAND THE LARGEST SHARE OF THE TISSUE DIAGNOSTICS MARKET IN NORTH AMERICA DURING THE FORECAST PERIOD 77
FIGURE 25 EUROPE: TISSUE DIAGNOSTICS MARKET SNAPSHOT 86
FIGURE 26 BREAST CANCER TO FORM THE LARGEST DISEASE SEGMENT IN EUROPE IN 2017 89
FIGURE 27 ASIA: TISSUE DIAGNOSTICS MARKET SNAPSHOT 104
FIGURE 28 IMMUNOHISTOCHEMISTRY TO FORM THE LARGEST TECHNOLOGY SEGMENT IN ASIA IN 2017 107
FIGURE 29 ROW: TISSUE DIAGNOSTICS MARKET SNAPSHOT 116
FIGURE 30 HOSPITALS TO FORM THE LARGEST END-USER SEGMENT IN ROW IN 2017 119
FIGURE 31 TISSUE DIAGNOSTICS MARKET: MARKET SHARE (2016) 121
FIGURE 32 ROCHE: COMPANY SNAPSHOT 123
FIGURE 33 DANAHER: COMPANY SNAPSHOT 125
FIGURE 34 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT 128
FIGURE 35 ABBOTT: COMPANY SNAPSHOT 131
FIGURE 36 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT 133
FIGURE 37 MERCK: COMPANY SNAPSHOT 136
FIGURE 38 ABCAM: COMPANY SNAPSHOT 140
FIGURE 39 BD: COMPANY SNAPSHOT 142
FIGURE 40 QIAGEN : COMPANY SNAPSHOT 144

If the above report does not have the information suitable for your business, we can provide custom research that can be lucrative for your business or enhance your profession.